Latest Operational Updates News

Excelsior Capital Ltd has clarified its Special Interim Dividend payment of 241.43 cents per share, fully franked and payable on 20 March 2026, reinforcing its commitment to shareholder returns.

Lynas Rare Earths has secured a 10-year renewal of its Malaysian operating licence, providing a significant boost to its investment certainty and supply chain stability.

Nexalis Therapeutics reported a widening loss of $1.83 million for 2025, reflecting increased investment in product development and marketing. Despite the loss, the company boosted its cash reserves through equity raises and borrowings.

Bass Oil reported steady January production with a notable regulatory green light for its Vanessa gas field acquisition and a $3.5 million grant to accelerate the Kiwi gas field development.

Titomic Limited reports a significant drop in revenue and increased losses for the six months ending December 2025, alongside a strategic financial year change to align with global subsidiaries.

Bapcor Limited reported a statutory loss of $104.8 million for the first half of FY26 and announced a fully underwritten $200 million equity raising to strengthen its balance sheet and support operational recovery.

Lynas Rare Earths Ltd has reported a striking half-year turnaround with a 1260% surge in net profit, underpinned by rising rare earth prices and strategic expansions. The company also completed a major equity raise to fuel its ambitious Towards 2030 growth plan.

Medallion Metals Limited has extended the deadline for its acquisition of the Forrestania Nickel Operation from IGO Limited, with completion expected by 27 February 2026. The transaction remains on track despite a few outstanding conditions.

Mesoblast Limited is set to release its half-year financial results and operational update, spotlighting its FDA-approved cell therapy and expanding international partnerships.

WA Kaolin reported $2.7 million in sales for the December quarter, secured a $1.5 million working capital loan, and restructured $20.4 million of debt, while focusing on plant improvements and cost reductions to address negative margins.

Elevra Lithium reported solid Q2 FY26 production and revenue results while progressing its North American Lithium brownfield expansion and forging strategic supply partnerships.

Ophir High Conviction Fund reported a 6.24% increase in net assets to $765 million for the half-year ended December 2025, despite a sharp 62.7% fall in operating profit. The Fund’s portfolio performance slowed significantly, prompting no distributions during the period.